Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy
Conclusion: NGAL, KIM-1, calprotectin, and [TIMP-2] •[IGFBP7] had neither a prognostic value for the progression of IgAN, nor for the response to immunosuppression in the present sub-cohort of the STOP-IgAN trial. The search for appropriate biomarkers for an individualized treatment strategy in IgAN continues.Kidney Blood Press Res 2018;43:1563 –1572
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research